Resumen
Objetivo: Analizar los aspectos socioambientales, epidemiológicos y fisiopatológicos de la esporotricosis, centrándose en la transmisión zoonótica por gatos infectados, con el objetivo de apoyar estrategias de control y prevención. Revisión bibliográfica: La esporotricosis, causada por hongos del complejo Sporothrix schenckii, es una micosis endémica y desatendida con un impacto creciente en la salud pública, particularmente en Brasil, debido a su propagación zoonótica. La enfermedad se presenta de forma crónica o subaguda, con lesiones cutáneas polimórficas. El aumento del contacto entre humanos y gatos infectados, especialmente en áreas urbanas con condiciones sanitarias precarias, es un factor crítico para la transmisión. Históricamente, la esporotricosis fue descrita por primera vez en 1898, con brotes asociados a actividades agrícolas y, más recientemente, a la transmisión zoonótica mediada por Sporothrix brasiliensis. Los datos epidemiológicos destacan a Brasil como uno de los epicentros globales, con transmisión predominantemente a través de gatos infectados. La enfermedad se manifiesta en formas cutáneas (linfocutánea, fija, diseminada) y extracutáneas, variando según factores del huésped y la virulencia del hongo. El diagnóstico es un desafío y requiere métodos de laboratorio como cultivo e histopatología. Consideraciones finales: Un enfoque integral de la esporotricosis, que integre la salud humana, animal y ambiental, es esencial para su control. Estudios continuos y políticas públicas sólidas pueden mitigar los impactos de esta micosis emergente, especialmente en poblaciones vulnerables.
Referencias
ALMEIDA-PAES R, et al. Antibody Isotype and Subclass Responses in Human Patients With Different Clinical Presentations of Sporotrichosis. Mycoses, 2024; 67(9): 13793.
ALMEIDA-PAES R, et al. Refractory sporotrichosis due to Sporothrix brasiliensis in humans appears to be unrelated to in vivo resistance. Medical Mycology, 2017; 55(5): 507-517.
ALVAREZ CM, et al. Sporotrichosis: A Review of a Neglected Disease in the Last 50 Years in Brazil. Microorganisms, 2022; 10(11): 2152.
AUNG AK, et al. Pulmonary sporotrichosis: case series and systematic analysis of literature on clinico-radiological patterns and management outcomes. Medical mycology, 2013; 51(5): 534-544.
BARROS MBLM, et al. Sporothrix schenckii and Sporotrichosis. Clinical microbiology reviews, 2011; 24(4): 633-654.
BONIFAZ A e TIRADO-SÁNCHEZ A. Cutaneous disseminated and extracutaneous sporotrichosis: current status of a complex disease. Journal of Fungi, 2017; 3(1): 6.
BONIFAZ A, et al. Cutaneous disseminated sporotrichosis: clinical experience of 24 cases. Journal of the European Academy of Dermatology and Venereology, 2018; 32(2): 77-79.
CHAKRABARTI A, et al. Global epidemiology of sporotrichosis. Med Mycol, 2015; 53(1): 3-14.
CHENG S, et al. Current situation of sporotrichosis in China. Future Microbiology, 2024; 19(12): 1097-1106.
COLOMBO SA, et al. Emergence of zoonotic sporotrichosis due to Sporothrix brasiliensis in Minas Gerais, Brazil: A molecular approach to the current animal disease. Mycoses, 2023; 66(10): 911-922.
DE CARVALHO AS, et al. Innovations in Treating Sporotrichosis: Drug Repurposing and Lead Compound Synthesis. Current Organic Chemistry, 2024; 28(13): 991-1005.
DOS SANTOS AR, et al. Emergence of zoonotic sporotrichosis in Brazil: a genomic epidemiology study. The Lancet Microbe, 2024; 5(3): 282-290.
GARCIA MTP, et al. Elaboração e avaliação de uma ficha de notificação compulsória para a esporotricose humana. Escola Anna Nery, 2022; 26: 20210361
GREMIÃO IDF, et al. Geographic expansion of sporotrichosis, Brazil. Emerging infectious diseases, 2020; 26(3): 621.
GREMIÃO IDF, et al. Guideline for the management of feline sporotrichosis caused by Sporothrix brasiliensis and literature revision. Brazilian Journal of Microbiology, 2021; 52(1): 107-124.
KAUFFMAN CA. Central nervous system infection with other endemic mycoses: rare manifestation of blastomycosis, paracoccidioidomycosis, talaromycosis, and sporotrichosis. Journal of Fungi, 2019; 5(3): 64.
LOPES-BEZERRA LM, et al. Sporotrichosis between 1898 and 2017: The evolution of knowledge on a changeable disease and on emerging etiological agents. Med Mycol, 2018; 56(1): 126-143.
LUTZ A e SPLENDORE A. On a mycosis observed in men and mice: Contribution to the knowledge of the so-called sporotrichosis. Revista Médica de São Paulo, 1907; 21: 443-450.
MAGALHÃES VC, et al. Clinical factors associated with systemic sporotrichosis in Brazil. Mycoses, 2024; 67(1): 13656.
MARIMON R, et al. Sporothrix brasiliensis, S. globosa, and S. mexicana, three new Sporothrix species of clinical interest. Journal of Clinical Microbiology, 2007; 45(10): 3198-3206.
MESQUITA VA, et al. Zoonotic Sporotrichosis outbreak: Emerging public health threat in the Amazon State, Brazil. PLOS Neglected Tropical Diseases, 2024; 18(7): 12328.
MOUSSA TAA, et al. Origin and distribution of Sporothrix globosa causing sapronoses in Asia. J Med Microbiol, 2017; 66(5): 560-569.
OROFINO-COSTA R, et al. Sporotrichosis: an update on epidemiology, etiopathogenesis, laboratory and clinical therapeutics. Anais brasileiros de dermatologia, 2017; 92: 606-620.
QUEIROZ-TELLES F, et al. Cutaneous disseminated sporotrichosis in immunocompetent patient: Case report and literature review. In Med Mycol Case Rep, 2022; 36: 31-34.
QUEIROZ-TELLES F, et al. Sporothrix and Sporotrichosis. In N. Rezaei, Encyclopedia of Infection and Immunity, 2022; 376-396.
RABELLO VBS, et al. The Historical Burden of Sporotrichosis in Brazil: a Systematic Review of Cases Reported from 1907 to 2020. Braz J Microbiol, 2022; 53(1): 231-244. https ://doi.org/10.1007/s42770-021-00658-1.
RANGEL-GAMBOA L, et al. Update of phylogenetic and genetic diversity of Sporothrix schenckii sensu lato. Medical Mycology, 2015; 54(3): 248-255.
RODRIGUES AM, et al. The threat of emerging and re-emerging pathogenic Sporothrix species. Mycopathologia, 2020; 185(5): 813-842.
ROSSATO L. Sporothrix brasiliensis: aspectos imunológicos e virulência Dissertation, Universidade de São Paulo, São Paulo, Brazil, 2017.
SCHENCK BR. On refractory subcutaneous abscesses caused by a fungus possibly related to the Sporotricha. Bull John Hopkins Hosp, 1898; 9: 286-290.
UEMURA EVG e ROSSATO L. Sporotrichosis co‐infection with human immunodeficiency virus/acquired immunodeficiency syndrome. Mycoses, 2023; 66(10): 845-853.
VERDAN F, et al. Dendritic cell are able to differentially recognize Sporothrix schenckii antigens and promote Th1/Th17 response in vitro. Immunobiology, 2012; 217(8): 788-794.
ZHANG Y, et al. Phylogeography and evolutionary patterns in Sporothrix spanning more than 14 000 human and animal case reports. Persoonia-Molecular Phylogeny and Evolution of Fungi, 2015; 35(1): 1-20.
